journal article·2021-05-25Open access

Theranostic Near-Infrared-Active Conjugated Polymer Nanoparticles

Miao Zhao, Edward Leggett, Struan Bourke, Souzana Poursanidou, Sadie Carter-Searjeant, Steve Po, Marciano Palma do Carmo, Lea Ann Dailey, Philip Manning, Sean G. Ryan, Laura Urbano, Mark A. Green, Aliaksandra Rakovich

ACS Nano· Volume 15· Issue 5

Abstract

Conjugated polymer nanoparticles (CPNs) based on a common solar cell material (PTB7) have been prepared, and their potential in theranostic applications based on bioimaging and photosensitizing capabilities has been evaluated. The main absorption and emission bands of the prepared CPNs both fell within the NIR-I (650–950 nm) transparency window, allowing facile and efficient implementation of our CPNs as bioimaging agents, as demonstrated in this work for A549 human lung cancer cell cultures. The prepared CPN samples were also shown to produce reactive oxygen species (ROS) upon photoexcitation in the near-infrared or ultraviolet spectral regions, both in aqueous solutions and in HaCaT keratinocyte cell cultures. Importantly, we show that the photosensitizing ability of our CPNs was largely determined by the nature of the stabilizing shell: coating the CPNs with a Pluronic F-127 copolymer led to an improvement of photoinitiated ROS production, while using poly[styrene-co-maleic anhydride] instead completely quenched said process. This work therefore demonstrates that the photosensitizing capability of CPNs can be modulated via an appropriate selection of stabilizing material and highlights the significance of this parameter for the on-demand design of theranostic probes based on CPNs.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Luminescence and Fluorescent Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Physics Department, King’s College London, Strand Building, London, WC2R 2LS, U.K.

Department of Clinical, Pharmaceutical and Biological Sciences, University of Hertfordshire, College Lane, Hatfield, Hertfordshire AL10 9AB, U.K.

Department of Pharmaceutical Technology and Biopharmacy, University of Vienna, Vienna, 1090, Austria

Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, Tyne and Wear NE2 4HH, U.K.

Department of Physics, Astronomy and Mathematics, University of Hertfordshire, College Lane, Hatfield, Hertfordshire AL10 9AB, U.K.

Centre for Advanced Biomedical Imaging, University College London, Gower Street, London, WC1E 6BT, U.K.

Funding

Royal Society · National Institute for Health Research · China Scholarship Council

References (62)

Show source-provided references
1. 10.1038/nrc107110.1038/nrc1071 ↗
2. 10.3322/caac.2011410.3322/caac.20114 ↗
3. 10.1016/j.canlet.2012.07.02610.1016/j.canlet.2012.07.026 ↗
4. 10.1021/nn401187c10.1021/nn401187c ↗
5. 10.3389/fbioe.2019.0048710.3389/fbioe.2019.00487 ↗
6. 10.1016/j.cbpa.2018.03.01510.1016/j.cbpa.2018.03.015 ↗
7. 10.1016/S0002-9440(10)65006-710.1016/S0002-9440(10)65006-7 ↗
8. 10.1039/C6RA13016J10.1039/C6RA13016J ↗
9. 10.3390/polym1009096110.3390/polym10090961 ↗
10. 10.1016/j.bios.2008.07.02910.1016/j.bios.2008.07.029 ↗
11. 10.1016/j.biomaterials.2014.02.05310.1016/j.biomaterials.2014.02.053 ↗
12. 10.1021/ar900181310.1021/ar9001813 ↗
13. 10.1002/anie.20120513310.1002/anie.201205133 ↗
14. 10.1021/cr200263w10.1021/cr200263w ↗
15. 10.1002/adbi.20170010010.1002/adbi.201700100 ↗
16. 10.1039/C1JM14397B10.1039/C1JM14397B ↗
17. 10.1039/C9TB02582K10.1039/C9TB02582K ↗
18. 10.1021/acsanm.8b0101410.1021/acsanm.8b01014 ↗
19. 10.1002/smll.20160280710.1002/smll.201602807 ↗
20. 10.1002/adma.20140037910.1002/adma.201400379 ↗
21. Gesquiere A. J. · Med. Res. Arch. · 2018 · 6 · 23
22. 10.3390/jnt201000510.3390/jnt2010005 ↗
23. 10.1002/aenm.20170039010.1002/aenm.201700390 ↗
24. 10.1039/c2cc38243a10.1039/c2cc38243a ↗
25. 10.1021/la060188l10.1021/la060188l ↗
26. 10.1021/j100157a06410.1021/j100157a064 ↗
27. 10.1039/C9TB00937J10.1039/C9TB00937J ↗
28. 10.2217/nnm.16.510.2217/nnm.16.5 ↗
29. 10.1021/acsami.5b1035210.1021/acsami.5b10352 ↗
30. 10.1016/j.ijpharm.2007.04.03610.1016/j.ijpharm.2007.04.036 ↗
31. 10.1021/acs.jpcc.5b0780310.1021/acs.jpcc.5b07803 ↗
32. 10.1146/annurev-physchem-040513-10363910.1146/annurev-physchem-040513-103639 ↗
33. 10.1155/2014/69454110.1155/2014/694541 ↗
34. 10.1021/j100678a00110.1021/j100678a001 ↗
35. 10.1038/ncomms386710.1038/ncomms3867 ↗
36. 10.1021/acsami.7b0847310.1021/acsami.7b08473 ↗
37. 10.1039/b311429e10.1039/b311429e ↗
38. 10.1007/s10103-008-0539-110.1007/s10103-008-0539-1 ↗
39. 10.1039/cs981100020510.1039/cs9811000205 ↗
40. 10.1021/acs.jpcc.9b0995410.1021/acs.jpcc.9b09954 ↗
41. 10.1039/C7EE01403A10.1039/C7EE01403A ↗
42. 10.1007/s10895-012-1114-510.1007/s10895-012-1114-5 ↗
43. 10.1016/0009-2614(78)85129-X10.1016/0009-2614(78)85129-X ↗
44. 10.1021/ja00537a03010.1021/ja00537a030 ↗
45. 10.1007/s10895-018-2304-610.1007/s10895-018-2304-6 ↗
46. 10.1039/D0NR03771K10.1039/D0NR03771K ↗
47. 10.1039/C7MH00672A10.1039/C7MH00672A ↗
48. 10.3390/jfb1001000410.3390/jfb10010004 ↗
49. 10.1002/marc.20170061410.1002/marc.201700614 ↗
50. 10.1038/cdd.2009.4910.1038/cdd.2009.49 ↗
51. 10.1074/jbc.M31014520010.1074/jbc.M310145200 ↗
52. 10.1016/S0891-5849(97)00455-310.1016/S0891-5849(97)00455-3 ↗
53. 10.1016/S0006-8993(01)02688-910.1016/S0006-8993(01)02688-9 ↗
54. 10.1179/1351000212Y.000000001110.1179/1351000212Y.0000000011 ↗
55. Oda T. · Cancer Res. · 1987 · 47 · 3206
56. 10.1007/s12274-014-0641-610.1007/s12274-014-0641-6 ↗
57. 10.1038/nbt.333010.1038/nbt.3330 ↗
58. 10.2147/IJN.S7904510.2147/IJN.S79045 ↗
59. 10.1039/C4PY00039K10.1039/C4PY00039K ↗
60. 10.1016/j.jconrel.2015.04.03210.1016/j.jconrel.2015.04.032 ↗
61. 10.1016/j.ijpharm.2016.06.11810.1016/j.ijpharm.2016.06.118 ↗
62. 10.1186/s12951-019-0562-310.1186/s12951-019-0562-3 ↗